Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pfizer
Pfizer
Page 35 of 37
Leadership
Pfizer’s CEO Isn’t a Hero or a Villain
By
Geoff Colvin
November 25, 2015
Leadership
Why Washington is Tackling the Tax Inversion Problem All Wrong
By
Chris Matthews
November 25, 2015
Finance
Pfizer’s Allergan Deal is an Even Bigger Tax Dodge Than It’s Claiming
By
Stephen Gandel
November 24, 2015
Finance
Investors Aren’t Convinced the Pfizer-Allergan Deal is a Go
By
Stephen Gandel
November 23, 2015
Finance
Will the Pfizer Inversion Get It Booted From the Dow?
By
Chris Matthews
November 23, 2015
Finance
Pfizer/Allergan deal pushes 2015 into the record books
By
Dan Primack
November 23, 2015
Health
Prediction: Healthcare’s M&A Flood Will Ebb in 2016
By
Jen Wieczner
November 23, 2015
Finance
Why New Tax Inversion Rules Won’t Stop Pfizer-Allergan Deal
By
Stephen Gandel
November 20, 2015
Leadership
Will Lobbying Dollars Put Pfizer and Allergan On The Fast Track?
By
Paul Hodgson
November 20, 2015
Finance
Why Pfizer Is Headed for Splitsville After Allergan Merger
By
Jen Wieczner
November 19, 2015
Leadership
A Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By
Alan Murray
November 19, 2015
Tech
VW’s New Horror And Facebook 3Q–5 Things To Know Today
By
Laura Lorenzetti
and
Geoffrey Smith
November 4, 2015
Finance
Pfizer-Allergan could be a super inversion deal
By
Stephen Gandel
October 29, 2015
Features
Gunboat diplomacy and Apple earnings — 5 things to know today
By
Tom Huddleston Jr.
October 27, 2015
Features
Apple’s earnings, baseball, and a Fed meeting — 5 things to know this week
By
Tom Huddleston Jr.
October 25, 2015
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
AI
'Robots are going to be amongst us': Qualcomm exec says buckle up for the next 5 years. Your car is going to be the...
By
Nino Paoli
Success
As millions of Gen Zers face unemployment, McDonald's CEO dishes out some tough love career...
By
Preston Fore